Some adults in the Coachella Valley may qualify for GLP-1 weight loss drugs through a recently launched Medicare program. Medicare launched a temporary GLP-1 Bridge Program on July 1, which allows ...

Many pharmaceutical industry experts had expected that patients would prefer pills over injections, for convenience. Yet eight of 10 doctors said many are opting for the injectables.

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it ...

What happens when an expensive drug that works well for a condition affecting millions of people remains out of reach to many ...

People with obesity in the United States are being sorted between haves and have-nots. Primary care doctor Ian Huntington has ...

Starting July 1, eligible Medicare Part D beneficiaries will be able to go to the pharmacy and pick up their glucagon-like ...

The top weight-loss drug manufacturers are promoting the new Medicare GLP-1 Bridge as the Trump administration takes a ...

The real opportunity is to move beyond policies and narratives that pit specialties against one another,” presidents of the ...

President Donald Trump and former President Joe Biden both deserve plaudits for their efforts to make the new class of weight ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” program upgrades the answer to something more like “yes, but …” For the ...

Novo Nordisk claims Eli Lilly aired misleading ads comparing the pharma companies' respective weight-loss drugs, Wegovy and ...